Tata Elxsi Unveils ViTel Material Intelligence Platform for Medical Device Manufacturers
Tata Elxsi announced in a press release the launch of ViTel, a material intelligence platform for medical device manufacturers created in collaboration with Viridium AI. The solution was introduced at DeviceTalks Boston 2026, where Tata Elxsi presented its newest AI-based MedTech engineering and compliance tools.
ViTel is designed to help medical device makers manage material and supplier dependencies, assess sourcing exposure, evaluate alternatives, and address regulatory and cost risks. It creates a unified material intelligence layer by connecting data from bills of materials, supplier documents, ERP, and PLM systems. The system uses Viridium AI's Knowledge Cloud, Chemical Digital Twin, and science-constrained AI models to build a product-material knowledge graph linking materials, chemicals, suppliers, and regulations.
Tata Elxsi integrated its MedTech engineering and regulatory expertise into ViTel, enabling the platform to support decision-making across sourcing, quality, and compliance. The solution was co-developed under Tata Elxsi's STEP UP co-innovation program for deep technology companies. Viridium AI contributed its material intelligence platform and domain-specific AI models to the collaboration.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 BOC Group Adds AI Assistant to ADOIT 21 Oct 16 Huawei Brings Upgraded Stellar Network Solution to Europe Oct 16 Element to Manage Waymo's Toronto Fleet for 2028 Launch Oct 16 CTM and Huawei Plan AI Network Security Upgrades in Macao Oct 16 Huawei and 14 partners form Global AI CITY allianceMore from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Seeq and Cognizant Collaborate on Industrial AI for Drug Manufacturing
XtalPi and Fangda Carbon Deploy AI for Graphite Electrode Production
TresVista Selects Farsight AI Platform for Client Work
Tucuvi Joins Microsoft Pegasus Program
Veeva to Showcase Falcon and Vault AI at Boston Summit
Daily AI Brief: the AI news that matters, in your inbox.